Pharmaceutical News and Articles

PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune HPV in HPV16-Positive Head and Neck Cancer

PDS Biotechnology Corporation (Nasdaq PDSB) ( PDS Biotech or the Company ), a late-stage immunotherapy company focused on transforming how the immune system tar

Amgen and Kyowa Kirin Provide Top-Line Results from Rocatinlimab Phase 3 Ignite Study in Adults with Moderate to Severe Atopic Dermatitis

Amgen (NASDAQ AMGN) and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE 4151) today announced new results from the ongoing ROCKET Phase 3 clinical trial program evaluat

Icotrokinra Results Show Potential to Set a New Standard of Treatment in Plaque Psoriasis

SPRING HOUSE, Pa. (March 8, 2025) Johnson Johnson (NYSE JNJ) today announced new icotrokinra (JNJ-2113) data from its comprehensive Phase 3 clinical program and

Q32 Bio Presents Results from SIGNAL-AA Part A Clinical Trial Evaluating Bempikibart in Patients with Alopecia Areata

Q32 Bio Inc. (Nasdaq QTTB) ( Q32 Bio ), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the Furoscix Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease

1 in 3 Kids Has Dental Problems, Poll Finds

More than 1 in 3 parents say their child has struggled with cavities, stained teeth, gum problems or tooth pain in the past two years, a new national poll shows

Four in 10 Adults With Chronic Pain Report Depression, Anxiety

Approximately 40 percent of adults with chronic pain experience depression or anxiety, according to a review published online March 7 in JAMA Network Open. Rach

One in Five Idiopathic Pulmonary Fibrosis Deaths May Be Due to Occupational Exposures

Roughly one in five (21 percent) of idiopathic pulmonary fibrosis (IPF) deaths might be related to occupational exposures, according to research published in th

Stillbirth Rates Are Highest in the South

Women in the U.S. South are three times more likely to lose a baby in late pregnancy than mothers in other regions, a new study reports. The study, exclusively

Recent Decade Saw No Change in Diabetes Prevalence in U.S. Adults

Between 2013 and 2023, there was no change in the prevalence of diabetes among U.S. adults, but glycemic control worsened, according to a research letter publis